| Primary |
| Parkinson's Disease |
37.4% |
| Product Used For Unknown Indication |
21.3% |
| Restless Legs Syndrome |
21.3% |
| Drug Use For Unknown Indication |
5.7% |
| Parkinsonism |
2.6% |
| Depression |
1.7% |
| Hypertension |
1.7% |
| Epilepsy |
1.3% |
| Pain |
1.3% |
| Muscle Spasms |
0.9% |
| Seasonal Allergy |
0.9% |
| Angina Pectoris |
0.4% |
| Anxiety |
0.4% |
| Back Pain |
0.4% |
| Benign Prostatic Hyperplasia |
0.4% |
| Blood Cholesterol Increased |
0.4% |
| Bronchitis |
0.4% |
| Cardiac Disorder |
0.4% |
| Cystitis Interstitial |
0.4% |
| Dyskinesia |
0.4% |
|
| Medication Error |
10.0% |
| Sudden Onset Of Sleep |
8.3% |
| Syncope |
8.3% |
| Product Quality Issue |
6.7% |
| Wrong Drug Administered |
6.7% |
| Drug Ineffective |
5.0% |
| Hallucination |
5.0% |
| Nausea |
5.0% |
| Tachycardia |
5.0% |
| Tremor |
5.0% |
| Vomiting |
5.0% |
| Adverse Drug Reaction |
3.3% |
| Drug Dispensing Error |
3.3% |
| Gambling |
3.3% |
| Haemoglobin Decreased |
3.3% |
| Malaise |
3.3% |
| Paraesthesia |
3.3% |
| Residual Urine Volume Increased |
3.3% |
| Somnolence |
3.3% |
| Stereotypy |
3.3% |
|
| Secondary |
| Parkinson's Disease |
29.7% |
| Drug Use For Unknown Indication |
22.8% |
| Restless Legs Syndrome |
14.5% |
| Product Used For Unknown Indication |
11.6% |
| Hypertension |
3.9% |
| Prophylaxis |
3.6% |
| Arteriosclerosis Coronary Artery |
1.8% |
| Colon Cancer |
1.8% |
| Thrombosis |
1.8% |
| Thyroidectomy |
1.8% |
| Osteoporosis |
1.5% |
| Cataplexy |
0.9% |
| Somnolence |
0.9% |
| Constipation |
0.6% |
| Depression |
0.6% |
| Dystonia |
0.6% |
| Gait Disturbance |
0.6% |
| Malignant Melanoma |
0.6% |
| Anxiety |
0.3% |
| Arthritis |
0.3% |
|
| Medication Error |
12.5% |
| Pathological Gambling |
12.5% |
| Adverse Event |
6.9% |
| Gambling |
6.9% |
| Vertigo |
6.9% |
| Musculoskeletal Stiffness |
5.6% |
| Off Label Use |
5.6% |
| Arthralgia |
4.2% |
| Drug Hypersensitivity |
4.2% |
| Syncope |
4.2% |
| Venous Thrombosis |
4.2% |
| Vision Blurred |
4.2% |
| Death |
2.8% |
| Hallucination |
2.8% |
| Insomnia |
2.8% |
| Myocardial Infarction |
2.8% |
| Nausea |
2.8% |
| Oedema Peripheral |
2.8% |
| Paraesthesia |
2.8% |
| Transient Ischaemic Attack |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.6% |
| Drug Use For Unknown Indication |
24.2% |
| Parkinson's Disease |
11.3% |
| Rheumatoid Arthritis |
5.7% |
| Pain |
4.4% |
| Restless Legs Syndrome |
4.2% |
| Depression |
4.0% |
| Hypertension |
3.0% |
| Vitamin Supplementation |
2.4% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Blood Cholesterol Increased |
1.3% |
| Insomnia |
1.2% |
| Osteoarthritis |
1.2% |
| Anxiety |
1.2% |
| Supplementation Therapy |
1.1% |
| Crohn's Disease |
1.0% |
| Muscle Spasms |
1.0% |
| Pyrexia |
1.0% |
| Arthritis |
0.9% |
| Retinal Detachment |
0.9% |
|
| Sudden Onset Of Sleep |
9.5% |
| Vomiting |
9.5% |
| Visual Acuity Reduced |
6.7% |
| Pain |
5.7% |
| Pain In Extremity |
5.7% |
| Renal Failure Acute |
5.7% |
| Drug Ineffective |
4.8% |
| Flushing |
4.8% |
| Injection Site Pain |
4.8% |
| Respiratory Failure |
4.8% |
| Weight Increased |
4.8% |
| Headache |
3.8% |
| Hyponatraemia |
3.8% |
| Incorrect Dose Administered |
3.8% |
| Neuroleptic Malignant Syndrome |
3.8% |
| Tooth Extraction |
3.8% |
| Transient Ischaemic Attack |
3.8% |
| Urinary Tract Infection |
3.8% |
| Weight Decreased |
3.8% |
| Anaemia |
2.9% |
|
| Interacting |
| Parkinson's Disease |
100.0% |
|
|
